TrialEuropean heart journal2017

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Nazzareno Galiè et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.